Literature DB >> 7605386

Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration.

M R Malinow1, J Levenson, P Giral, F J Nieto, M Razavian, P Segond, A Simon.   

Abstract

Elevated concentration of plasma homocyst(e)ine is an independent risk factor for clinical atherosclerosis. In this study, the concentration of plasma homocyst(e)ine in men who lacked a history of atherosclerotic disease was correlated with hemodynamic, rheological and biochemical parameters. Hypertensive subjects had higher concentrations of plasma homocyst(e)ine than normotensive subjects. Positive correlations were found between concentrations of plasma homocyst(e)ine and several risk factors, but some of these correlations disappeared when they were adjusted for other variables. However, multivariate analyses demonstrated that systolic blood pressure, plasma uric acid, and hematocrit were predictors of concentrations of plasma homocyst(e)ine, after adjusting for certain risk factors. The possible significance of these interrelationships in atherogenesis require further study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605386     DOI: 10.1016/0021-9150(94)05481-w

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

1.  Association between low red blood cell 5-methyltetrahydrofolate and hyperhomocysteinaemia with hypertension : a cross-sectional study.

Authors:  Jamal Golbahar; Esmael Mostafavi
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-02-19

2.  Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.

Authors:  Neetu Tyagi; Natia Qipshidze; Utpal Sen; Walter Rodriguez; Alexander Ovechkin; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-08

Review 3.  Homocysteine to hydrogen sulfide or hypertension.

Authors:  Utpal Sen; Paras K Mishra; Neetu Tyagi; Suresh C Tyagi
Journal:  Cell Biochem Biophys       Date:  2010-07       Impact factor: 2.194

Review 4.  Diagnosis and treatment of hyperhomocysteinemia.

Authors:  M E Keebler; C De Souza ; V Fonseca
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

Review 5.  Mechanisms of homocysteine-induced glomerular injury and sclerosis.

Authors:  Fan Yi; Pin-Lan Li
Journal:  Am J Nephrol       Date:  2007-11-07       Impact factor: 3.754

Review 6.  Homocysteine and blood pressure.

Authors:  Coen van Guldener; Prabath W B Nanayakkara; Coen D A Stehouwer
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

7.  Effect of salvianolic acid B and paeonol on blood lipid metabolism and hemorrheology in myocardial ischemia rabbits induced by pituitruin.

Authors:  Qian Yang; Siwang Wang; Yanhua Xie; Jianbo Wang; Hua Li; Xuanxuan Zhou; Wenbo Liu
Journal:  Int J Mol Sci       Date:  2010-09-28       Impact factor: 5.923

8.  Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.

Authors:  David Lominadze; Neetu Tyagi; Utpal Sen; Alexander Ovechkin; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2012-08-12       Impact factor: 3.396

9.  Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.

Authors:  Amy Z Fan; Ajay Yesupriya; Man-huei Chang; Meaghan House; Jing Fang; Renée Ned; Donald Hayes; Nicole F Dowling; Ali H Mokdad
Journal:  BMC Med Genet       Date:  2010-01-15       Impact factor: 2.103

10.  The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men.

Authors:  Young Seoub Hong; Myeong Jin Lee; Kyeong Hee Kim; Sang Hwa Lee; Yong Hwan Lee; Byoung Gwon Kim; Baekgeun Jeong; Hyeong Ryeol Yoon; Hisahide Nishio; Joon Youn Kim
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.